Skip to main content
Clinical Trials/JPRN-UMIN000050100
JPRN-UMIN000050100
Recruiting
未知

Exploratory study to elucidate the significance of biomarker measurement by liquid biopsy over time in patients with hepatobiliary and pancreatic malignancies during systemic therapy - Liquid biopsy study during systemic therapy for hepatobiliary pancreatic cancer

Fujita Health University hospital0 sites1,000 target enrollmentJanuary 24, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepato-biliary pancreatic malignant tumor
Sponsor
Fujita Health University hospital
Enrollment
1000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2023
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with serious complications 2\. Patients who are judged by the investigator to be ineligible for the safe conduct of this study

Outcomes

Primary Outcomes

Not specified

Similar Trials